Photo-induced cross-linking of unmodified proteins

Last updated

Photo-Induced Cross-Linking of Unmodified Proteins (PICUP) is a protein cross-linking method by visible light irradiation of a photocatalyst in the presence of an electron acceptor and the protein of interest. [1] Irradiation results in a highly reactive protein radical that forms a covalent bond between the amino acid side chains of the proteins to be linked. Cross-linking methods developed prior to PICUP, including the use of physical, oxidative, and chemical cross-linkers, often require more time and result in protein byproducts. [2] In addition, the cross-linked protein yield is very low due to the multifunctionality of the cross-linking reagents.

Contents

The process was invented (US6613582B1) in 1999 to utilize protein cross-linking techniques to analyze the interactions between polypeptides as well as structural differences proteins undergo in a catalytic pathway. The techniques in the 20th century were not sufficient to be applied to cross-link fast and transient changes of these proteins in high yield. PICUP allowed for rapid (<1 second) and high production of covalently-linked proteins in close proximity with each other. [2]

History

Fancy and Kodadek

Fancy and Kodadek's invention of PICUP in 1999 was the first time proteins cross-linking was able to be performed in such a short period of time (1 second) and without modifying the structure of the proteins in question. [2] Additionally, PICUP was able to be performed at physiological pH of 7.4, which opened doors for further application of protein cross-linking such as studying the biochemical mechanisms that proteins participate in the human body. In addition, irradiation by visible light in PICUP is useful because many biomolecules that participate in metabolic pathways to be analyzed do no absorb light with wavelengths below the range for UV light, allowing for cross-links without denaturation. [2]

Bitan, Lomakin, and Teplow

In 2001, Gal Bitan, Aleksey Lomakin, and David B. Teplow applied PICUP to study amyloid β-protein (Aβ) oligomerization, which is observed in Alzheimer's disease. [3] PICUP allowed for identifying and quantifying the Aβ oligomers that are metastable because of its ability to rapidly cross-link. [3] Coupling PICUP with sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), the distribution of oligomers in rapid equilibrium was quantified. [3] This application allowed for the study of amyloidogenic proteins associated with neurodegenerative diseases and opened doors for possible future therapeutic mechanisms. Neurodegenerative diseases are currently suggested to be the result of neurotoxic proteins, so the ability to study their oligomer distribution is effective in understanding how and under what conditions these oligomers are formed.

Mechanism

APS and Ru(Bpy)3 reaction to produce excited Ru(Bpy)3 RuBpy and APS Reaction.png
APS and Ru(Bpy)3 reaction to produce excited Ru(Bpy)3

The mechanism of PICUP require the tris(bipyridyl)Ru(II) complex, an electron acceptor, ammonium persulfate (APS), and reactive amino acid side chains. [2] Tris(2,2′-bipyridyl)dichlororuthenium(II) hexahydrate, a tris(bipyridyl)Ru(II) complex, initially contains a Ru2+. [4] Upon visible light irradiation and in the presence of ammonium persulfate (APS), Ru2+ enters its excited state and is oxidized to Ru3+. [4] Ru3+ is now an extremely reactive oxidizer that only wants to accept one electron instead of the standard two. [4] The reaction can proceed in the absence of an electron acceptor, but it will have a much lower efficiency, producing byproducts resulting from the excited Ru(Bpy)3 reacting with oxygen. [5] As an effective single electron oxidizer, Ru3+ will pick up a single electron from amino acids of the neighboring proteins, most commonly Tryptophan and Tyrosine. [4] This produces a radical that is highly unstable on the amino acid side chains, which proceeds through reactions to reach a more stable state.

Formation of covalent bond between amino acid side chains (Tyrosine) Forming dimers.png
Formation of covalent bond between amino acid side chains (Tyrosine)

The unpaired single electron on the side chain reacts with another amino acid side chain of a polypeptide in the vicinity, resulting in a dimer with a covalent bond. [4] With the regeneration of Ru2+ when Ru3+ picks up an electron from the amino acids allows for continuous formation of radicals with Ru3+ being oxidized by APS. [2]

In the PCR tube that the reaction takes place in, numerous unstable protein radicals come in contact with each other through simple diffusion and react both intra- and intermolecularly to achieve a more stable state. The monomeric protein radicals are able to achieve a lower energy state through forming a covalent bond to produce a dimer and releasing a hydrogen atom. [4] PLEASE NOTE: The image mistakenly shows the release of a proton and should not be used in this form (See also ref. 4). The creator has been contacted. This newly formed dimer is also able to react with numerous other monomers or dimers through the same mechanism, creating higher numbers of cross-linked oligomers. [4] This allows for a distribution of variety of oligomers to be present in the mixture.

Method

Camera apparatus used to irradiate the protein mixture PICUP Apparatus .jpg
Camera apparatus used to irradiate the protein mixture

In every experiment, it is important to determine the relative concentration of the protein in question, ammonium persulfate, and Tris(2,2′-bipyridyl)dichlororuthenium(II) hexahydrate that will be used in the protein cross-linking experiment. Previous experiments have shown that for amyloid β-protein (Aβ), the peptide assumed to cause toxicity in Alzheimer's disease, the ratio of protein: Ru(Bpy)3: APS is 1:2:40. [3] The ratio of Ru(Bpy)3 and APS is suggested to be kept at this ratio, but the appropriate concentration of a given protein can vary. For many proteins that PICUP has not yet been used for, finding the appropriate concentrations can be done through trial and error. Generally, protein concentrations would fall in between 10 and 50μM, dissolved in the corresponding buffer, most likely sodium phosphate if testing for conditions at physiological pH. However, some studies of pure protein suggest that the protein to Ru(Bpy)3 ratio should be kept at 1:2 as well. [4] This level arises from the fact that the lower amount of Ru(Bpy)3 can lead to the protein sample appearing to have more than the actual number of higher order oligomers, and a greater amount of Ru(Bpy)3 can allow for artificial cross-linking byproducts.

The general method for PICUP is as follows:

  1. The appropriate amount of the protein is pipetted into the polymerase chain reaction tube (PCR). [6]
  2. Ammonium persulfate (APS) and Tris(2,2′-bipyridyl)dichlororuthenium(II) hexahydrate are added to the sample and mixed briefly. [6]
  3. The PCR tube is placed in a glass vial to hold it still inside the bellows of the camera that would irradiate the mixture. Upon closing the lid that covers the camera, pressing down the camera shutter illuminates the tube for however long you program the camera to irradiate for. Using the same camera for every replicate of the experiment ensures that the irradiation time and the distance from the light sourced is controlled for every PICUP experiment. [6]
  4. After the sample in the PCR tube is irradiated, a calculated amount of 1M Dithiothreitol (DTT) is immediately added to the mixture to quench the reaction. If the reaction is not quenched, the oligomers will continually aggregate and lower order oligomers will not be present in the mixture. In addition, if SDS-PAGE is to be used to analyze the oligomer distribution of the proteins after PICUP, DTT would also act as a denaturing agent to the proteins before gel electrophoresis. [6]

Applications

Using PICUP on protein complexes is useful in providing catalytic and kinetic information about these proteins, as catalytic mechanisms are rapid and PICUP allows for fast and highly efficient cross-linking of proteins. [5] Some epitope and affinity tags were shown to be unaffected by the PICUP reaction, enabling visualization of the cross-linked proteins. [5]

Furthermore, PICUP allows for visualization of quantitative bands of protein oligomer distribution when it is coupled with protein fractionation techniques. This combination is especially useful when examining the oligomers of neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, and Huntington's disease, that result from protein aggregation. [1] PICUP is extremely important when possible prevention and treatment procedures for these diseases are explored, as it is necessary to investigate the aggregation propensity of the respective amyloidogenic proteins.

See also

Related Research Articles

<span class="mw-page-title-main">Denaturation (biochemistry)</span> Loss of structure in proteins and nucleic acids due to external stress

In biochemistry, denaturation is a process in which proteins or nucleic acids lose the quaternary structure, tertiary structure, and secondary structure which is present in their native state, by application of some external stress or compound such as a strong acid or base, a concentrated inorganic salt, an organic solvent, agitation and radiation or heat. If proteins in a living cell are denatured, this results in disruption of cell activity and possibly cell death. Protein denaturation is also a consequence of cell death. Denatured proteins can exhibit a wide range of characteristics, from conformational change and loss of solubility to aggregation due to the exposure of hydrophobic groups. The loss of solubility as a result of denaturation is called coagulation. Denatured proteins lose their 3D structure and therefore cannot function.

<span class="mw-page-title-main">Protein primary structure</span> Linear sequence of amino acids in a peptide or protein

Protein primary structure is the linear sequence of amino acids in a peptide or protein. By convention, the primary structure of a protein is reported starting from the amino-terminal (N) end to the carboxyl-terminal (C) end. Protein biosynthesis is most commonly performed by ribosomes in cells. Peptides can also be synthesized in the laboratory. Protein primary structures can be directly sequenced, or inferred from DNA sequences.

<span class="mw-page-title-main">Active site</span> Active region of an enzyme

In biology and biochemistry, the active site is the region of an enzyme where substrate molecules bind and undergo a chemical reaction. The active site consists of amino acid residues that form temporary bonds with the substrate and residues that catalyse a reaction of that substrate. Although the active site occupies only ~10–20% of the volume of an enzyme, it is the most important part as it directly catalyzes the chemical reaction. It usually consists of three to four amino acids, while other amino acids within the protein are required to maintain the tertiary structure of the enzymes.

Biology is the study of life and its processes. Biologists study all aspects of living things, including all of the many life forms on earth and the processes in them that enable life. These basic processes include the harnessing of energy, the synthesis and duplication of the materials that make up the body, the reproduction of the organism and many other functions. Biology, along with chemistry and physics is one of the major disciplines of natural science.

<span class="mw-page-title-main">Amyloid</span> Insoluble protein aggregate with a fibrillar morphology

Amyloids are aggregates of proteins characterised by a fibrillar morphology of typically 7–13 nm in diameter, a beta sheet (β-sheet) secondary structure and ability to be stained by particular dyes, such as Congo red. In the human body, amyloids have been linked to the development of various diseases. Pathogenic amyloids form when previously healthy proteins lose their normal structure and physiological functions (misfolding) and form fibrous deposits within and around cells. These protein misfolding and deposition processes disrupt the healthy function of tissues and organs.

<span class="mw-page-title-main">Oligomer</span> Molecule composed of copies of a small unit

In chemistry and biochemistry, an oligomer is a molecule that consists of a few repeating units which could be derived, actually or conceptually, from smaller molecules, monomers. The name is composed of Greek elements oligo-, "a few" and -mer, "parts". An adjective form is oligomeric.

<span class="mw-page-title-main">Cross-link</span> Bond that links one polymer chain to another

In chemistry and biology a cross-link is a bond or a short sequence of bonds that links one polymer chain to another. These links may take the form of covalent bonds or ionic bonds and the polymers can be either synthetic polymers or natural polymers.

Site-directed spin labeling (SDSL) is a technique for investigating the structure and local dynamics of proteins using electron spin resonance. The theory of SDSL is based on the specific reaction of spin labels with amino acids. A spin label's built-in protein structure can be detected by EPR spectroscopy. SDSL is also a useful tool in examinations of the protein folding process.

<span class="mw-page-title-main">Amyloid beta</span> Group of peptides

Amyloid beta denotes peptides of 36–43 amino acids that are the main component of the amyloid plaques found in the brains of people with Alzheimer's disease. The peptides derive from the amyloid precursor protein (APP), which is cleaved by beta secretase and gamma secretase to yield Aβ in a cholesterol-dependent process and substrate presentation. Aβ molecules can aggregate to form flexible soluble oligomers which may exist in several forms. It is now believed that certain misfolded oligomers can induce other Aβ molecules to also take the misfolded oligomeric form, leading to a chain reaction akin to a prion infection. The oligomers are toxic to nerve cells. The other protein implicated in Alzheimer's disease, tau protein, also forms such prion-like misfolded oligomers, and there is some evidence that misfolded Aβ can induce tau to misfold.

<span class="mw-page-title-main">Molecular tweezers</span>

Molecular tweezers, and molecular clips, are host molecules with open cavities capable of binding guest molecules. The open cavity of the molecular tweezers may bind guests using non-covalent bonding which includes hydrogen bonding, metal coordination, hydrophobic forces, van der Waals forces, π-π interactions, and/or electrostatic effects. These complexes are a subset of macrocyclic molecular receptors and their structure is that the two "arms" that bind the guest molecule between them are only connected at one end leading to a certain flexibility of these receptor molecules.

<span class="mw-page-title-main">PRNP</span> Protein involved in multiple prion diseases

Major prion protein(PrP), is encoded in the human by the PRNP gene also known as CD230 (cluster of differentiation 230). Expression of the protein is most predominant in the nervous system but occurs in many other tissues throughout the body.

<span class="mw-page-title-main">Tris(bipyridine)ruthenium(II) chloride</span> Chemical compound

Tris(bipyridine)ruthenium(II) chloride is the chloride salt coordination complex with the formula [Ru(bpy)3]2+ 2Cl. This polypyridine complex is a red crystalline salt obtained as the hexahydrate, although all of the properties of interest are in the cation [Ru(bpy)3]2+, which has received much attention because of its distinctive optical properties. The chlorides can be replaced with other anions, such as PF6.

<span class="mw-page-title-main">Proteinopathy</span> Medical condition

In medicine, proteinopathy, or proteopathy, protein conformational disorder, or protein misfolding disease refers to a class of diseases in which certain proteins become structurally abnormal, and thereby disrupt the function of cells, tissues and organs of the body. Often the proteins fail to fold into their normal configuration; in this misfolded state, the proteins can become toxic in some way or they can lose their normal function. The proteinopathies include such diseases as Creutzfeldt–Jakob disease and other prion diseases, Alzheimer's disease, Parkinson's disease, amyloidosis, multiple system atrophy, and a wide range of other disorders. The term proteopathy was first proposed in 2000 by Lary Walker and Harry LeVine.

<span class="mw-page-title-main">Electrochemiluminescence</span> Emission of light from electrochemical reactions

Electrochemiluminescence or electrogenerated chemiluminescence (ECL) is a kind of luminescence produced during electrochemical reactions in solutions. In electrogenerated chemiluminescence, electrochemically generated intermediates undergo a highly exergonic reaction to produce an electronically excited state that then emits light upon relaxation to a lower-level state. This wavelength of the emitted photon of light corresponds to the energy gap between these two states. ECL excitation can be caused by energetic electron transfer (redox) reactions of electrogenerated species. Such luminescence excitation is a form of chemiluminescence where one/all reactants are produced electrochemically on the electrodes.

<span class="mw-page-title-main">Protein aggregation</span> Accumulation of clumps of misfolded or disordered proteins

In molecular biology, protein aggregation is a phenomenon in which intrinsically-disordered or mis-folded proteins aggregate either intra- or extracellularly. Protein aggregates have been implicated in a wide variety of diseases known as amyloidoses, including ALS, Alzheimer's, Parkinson's and prion disease.

<span class="mw-page-title-main">Carbon nanotube chemistry</span>

Carbon nanotube chemistry involves chemical reactions, which are used to modify the properties of carbon nanotubes (CNTs). CNTs can be functionalized to attain desired properties that can be used in a wide variety of applications. The two main methods of CNT functionalization are covalent and non-covalent modifications.

The Alzheimer's disease biomarkers are neurochemical indicators used to assess the risk or presence of the disease. The biomarkers can be used to diagnose Alzheimer's disease (AD) in a very early stage, but they also provide objective and reliable measures of disease progress. It is imperative to diagnose AD disease as soon as possible, because neuropathologic changes of AD precede the symptoms by years. It is well known that amyloid beta (Aβ) is a good indicator of AD disease, which has facilitated doctors to accurately pre-diagnose cases of AD. When Aβ peptide is released by proteolytic cleavage of amyloid-beta precursor protein, some Aβ peptides that are solubilized are detected in CSF and blood plasma which makes AB peptides a promising candidate for biological markers. It has been shown that the amyloid beta biomarker shows 80% or above sensitivity and specificity, in distinguishing AD from dementia. It is believed that amyloid beta as a biomarker will provide a future for diagnosis of AD and eventually treatment of AD.

<span class="mw-page-title-main">P3 peptide</span>

p3 peptide also known as amyloid β- peptide (Aβ)17–40/42 is the peptide resulting from the α- and γ-secretase cleavage from the amyloid precursor protein (APP). It is known to be the major constituent of diffuse plaques observed in Alzheimer's disease (AD) brains and pre-amyloid plaques in people affected of Down syndrome. However, p3 peptide's role in these diseases is not truly known yet.

<span class="smallcaps"><span style="font-variant: small-caps; text-transform: lowercase;">L</span></span>-Photo-leucine Chemical compound

l-Photo-leucine is a synthetic derivative of the l-leucine amino acid that is used as its natural analog and is characterized for having photo-reactivity, which makes it suitable for observing and characterizing protein-protein interactions (PPI). When a protein containing this amino acid (A) is exposed to ultraviolet light while interacting with another protein (B), the complex formed from these two proteins (AB) remains attached and can be isolated for study.

Joan-Emma Shea is an American chemist who is a professor at the University of California, Santa Barbara. Her research considers chaperone-mediated protein folding. She is a Fellow of both the American Physical Society and the American Chemical Society, and the Editor-in-Chief of the Journal of Physical Chemistry.

References

  1. 1 2 Rahimi, Farid; Maiti, Panchanan; Bitan, Gal (2009-01-12). "Photo-induced cross-linking of unmodified proteins (PICUP) applied to amyloidogenic peptides". Journal of Visualized Experiments (23). doi:10.3791/1071. ISSN   1940-087X. PMC   2763294 . PMID   19229175.
  2. 1 2 3 4 5 6 Fancy, David A.; Kodadek, Thomas (1999-05-25). "Chemistry for the analysis of protein–protein interactions: Rapid and efficient cross-linking triggered by long wavelength light". Proceedings of the National Academy of Sciences of the United States of America. 96 (11): 6020–6024. Bibcode:1999PNAS...96.6020F. doi: 10.1073/pnas.96.11.6020 . ISSN   0027-8424. PMC   26828 . PMID   10339534.
  3. 1 2 3 4 Bitan, Gal; Lomakin, Aleksey; Teplow, David B. (2001-09-14). "Amyloid β-Protein Oligomerization PRENUCLEATION INTERACTIONS REVEALED BY PHOTO-INDUCED CROSS-LINKING OF UNMODIFIED PROTEINS". Journal of Biological Chemistry. 276 (37): 35176–35184. doi: 10.1074/jbc.M102223200 . ISSN   0021-9258. PMID   11441003.
  4. 1 2 3 4 5 6 7 8 Bitan, Gal (2006). "Structural Study of Metastable Amyloidogenic Protein Oligomers by Photo‐Induced Cross‐Linking of Unmodified Proteins". Structural study of metastable amyloidogenic protein oligomers by photo-induced cross-linking of unmodified proteins. Methods in Enzymology. Vol. 413. pp. 217–236. doi:10.1016/S0076-6879(06)13012-8. ISBN   9780121828189. ISSN   0076-6879. PMC   2782599 . PMID   17046399.
  5. 1 2 3 Fancy, D. A.; Denison, C.; Kim, K.; Xie, Y.; Holdeman, T.; Amini, F.; Kodadek, T. (September 2000). "Scope, limitations and mechanistic aspects of the photo-induced cross-linking of proteins by water-soluble metal complexes". Chemistry & Biology. 7 (9): 697–708. doi: 10.1016/s1074-5521(00)00020-x . ISSN   1074-5521. PMID   10980450.
  6. 1 2 3 4 Vollers, Sabrina S.; Teplow, David B.; Bitan, Gal (2004). Amyloid Proteins. Methods in Molecular Biology. Vol. 299. pp. 011–018. doi:10.1385/1-59259-874-9:011. ISBN   978-1-59259-874-8. PMID   15980592. S2CID   34037607.